Shanghai Xinzhi Medical Technology Co., Ltd. announced a private placement of common shares for the gross proceeds of CNY 15 million on April 14, 2023. The transaction will include participation from new investor Shanghai Bio-heart Biological Technology Co., Ltd. Post completion, Shanghai Bio-heart Biological Technology Co., Ltd. will hold 14.79% stake in exchange for CNY 361,144 of registered capital of the company.
Shanghai Bio-heart Biological Technology Co., Ltd.
Equities
2185
CNE100004JH3
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.07 HKD | 0.00% | 0.00% | -39.47% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-39.47% | 64.53M | |
+16.43% | 133B | |
-8.13% | 10.93B | |
-12.07% | 7.84B | |
+42.65% | 5.71B | |
-20.18% | 4.82B | |
+8.48% | 3.44B | |
-20.37% | 2.45B | |
-18.39% | 1.94B | |
-16.75% | 1.88B |
- Stock Market
- Equities
- 2185 Stock
- News Shanghai Bio-heart Biological Technology Co., Ltd.
- Shanghai Xinzhi Medical Technology Co., Ltd. announced that it expects to receive CNY 15 million in funding from Shanghai Bio-heart Biological Technology Co., Ltd.